These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 15917662

  • 1. Association of caspase-2 with the promyelocytic leukemia protein nuclear bodies.
    Tang J, Xie W, Yang X.
    Cancer Biol Ther; 2005 Jun; 4(6):645-9. PubMed ID: 15917662
    [Abstract] [Full Text] [Related]

  • 2. Are promyelocytic leukaemia protein nuclear bodies a scaffold for caspase-2 programmed cell death?
    Sanchez-Pulido L, Valencia A, Rojas AM.
    Trends Biochem Sci; 2007 Sep; 32(9):400-6. PubMed ID: 17693089
    [Abstract] [Full Text] [Related]

  • 3. Role of nuclear bodies in apoptosis signalling.
    Krieghoff-Henning E, Hofmann TG.
    Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
    [Abstract] [Full Text] [Related]

  • 4. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts.
    Meinecke I, Cinski A, Baier A, Peters MA, Dankbar B, Wille A, Drynda A, Mendoza H, Gay RE, Hay RT, Ink B, Gay S, Pap T.
    Proc Natl Acad Sci U S A; 2007 Mar 20; 104(12):5073-8. PubMed ID: 17360386
    [Abstract] [Full Text] [Related]

  • 5. Modulation of the Zac1's transactivation and coactivation functions via PML and Daxx within distinct subcellular localizations.
    Ho CL, Huang YC, Tai CK, Liu ST, Wang JK, Wang WM, Huang SM.
    Int J Biochem Cell Biol; 2010 Jun 20; 42(6):902-10. PubMed ID: 20097304
    [Abstract] [Full Text] [Related]

  • 6. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
    Fu C, Ahmed K, Ding H, Ding X, Lan J, Yang Z, Miao Y, Zhu Y, Shi Y, Zhu J, Huang H, Yao X.
    Oncogene; 2005 Aug 18; 24(35):5401-13. PubMed ID: 15940266
    [Abstract] [Full Text] [Related]

  • 7. Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies.
    Reineke EL, Kao HY.
    Int J Biol Sci; 2009 May 22; 5(4):366-76. PubMed ID: 19471587
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Two-step colocalization of MORC3 with PML nuclear bodies.
    Mimura Y, Takahashi K, Kawata K, Akazawa T, Inoue N.
    J Cell Sci; 2010 Jun 15; 123(Pt 12):2014-24. PubMed ID: 20501696
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
    Frappier L.
    Virulence; 2011 Jun 15; 2(1):58-62. PubMed ID: 21217204
    [Abstract] [Full Text] [Related]

  • 12. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies.
    Bernardi R, Pandolfi PP.
    Nat Rev Mol Cell Biol; 2007 Dec 15; 8(12):1006-16. PubMed ID: 17928811
    [Abstract] [Full Text] [Related]

  • 13. Death-domain associated protein-6 (DAXX) mediated apoptosis in hantavirus infection is counter-balanced by activation of interferon-stimulated nuclear transcription factors.
    Khaiboullina SF, Morzunov SP, Boichuk SV, Palotás A, St Jeor S, Lombardi VC, Rizvanov AA.
    Virology; 2013 Sep 01; 443(2):338-48. PubMed ID: 23830076
    [Abstract] [Full Text] [Related]

  • 14. Proteasome-dependent dispersal of PML nuclear bodies in response to alkylating DNA damage.
    Conlan LA, McNees CJ, Heierhorst J.
    Oncogene; 2004 Jan 08; 23(1):307-10. PubMed ID: 14712236
    [Abstract] [Full Text] [Related]

  • 15. Dynamics of component exchange at PML nuclear bodies.
    Weidtkamp-Peters S, Lenser T, Negorev D, Gerstner N, Hofmann TG, Schwanitz G, Hoischen C, Maul G, Dittrich P, Hemmerich P.
    J Cell Sci; 2008 Aug 15; 121(Pt 16):2731-43. PubMed ID: 18664490
    [Abstract] [Full Text] [Related]

  • 16. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies.
    Kumada S, Uchihara T, Hayashi M, Nakamura A, Kikuchi E, Mizutani T, Oda M.
    J Neuropathol Exp Neurol; 2002 Nov 15; 61(11):984-91. PubMed ID: 12430715
    [Abstract] [Full Text] [Related]

  • 17. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
    Li Q, He Y, Wei L, Wu X, Wu D, Lin S, Wang Z, Ye Z, Lin SC.
    Oncogene; 2011 Mar 10; 30(10):1194-204. PubMed ID: 21057547
    [Abstract] [Full Text] [Related]

  • 18. TTRAP is a novel PML nuclear bodies-associated protein.
    Xu GL, Pan YK, Wang BY, Huang L, Tian L, Xue JL, Chen JZ, Jia W.
    Biochem Biophys Res Commun; 2008 Oct 24; 375(3):395-8. PubMed ID: 18706885
    [Abstract] [Full Text] [Related]

  • 19. Recruitment of human cytomegalovirus immediate-early 2 protein onto parental viral genomes in association with ND10 in live-infected cells.
    Sourvinos G, Tavalai N, Berndt A, Spandidos DA, Stamminger T.
    J Virol; 2007 Sep 24; 81(18):10123-36. PubMed ID: 17626080
    [Abstract] [Full Text] [Related]

  • 20. A novel GTPase, CRAG, mediates promyelocytic leukemia protein-associated nuclear body formation and degradation of expanded polyglutamine protein.
    Qin Q, Inatome R, Hotta A, Kojima M, Yamamura H, Hirai H, Yoshizawa T, Tanaka H, Fukami K, Yanagi S.
    J Cell Biol; 2006 Feb 13; 172(4):497-504. PubMed ID: 16461359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.